Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

The Food and Drug Administration on Friday approved a new nasal spray drug giant Pfizer says could offer “fast-acting relief” from migraines, launching a new form of medicine onto the market ...

New migraine pain relief may be on the way for the 28 million American sufferers, shows a promising new study. A new migraine drug under study that works differently than medications currently ...

The FDA announced approval on May 17 of a novel preventive treatment for migraine headaches. Aimovig is the first in a new class of migraine-specific drugs that works by blocking an action of a ...

THURSDAY, Nov. 29, 2017 -- Two new migraine drugs have shown promise in late-stage clinical trials. The drugs were designed specifically to target a pathway believed to be important in these ...

A recently approved preventative migraine drug called atogepant (branded Qulipta) seems to help even the most difficult cases, preliminary research out this week has found. The study showed that ...

Nov. 25 -- MONDAY, Nov. 24 (HealthDay News) -- A drug called telcagepant proved safe and effective in treating migraines and caused fewer side effects than the widely-used migraine drug ...

Two New Drugs To Treat Migraines Could Be On The Market Soon : Shots - Health News The first drugs designed specifically to prevent migraines have been found safe and effective in studies, ...